Search
IQVIA Holdings Inc
IQVAdd to Watchlist
190.275USD
+4.655+2.51%
Market hours （ET）Quotes delayed by 15 min
31.76BMarket Cap
23.43P/E TTM
More Details of IQVIA Holdings Inc Company
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
IQVIA Holdings Inc Info
Ticker SymbolIQV
Company nameIQVIA Holdings Inc
IPO dateMay 09, 2013
CEOBousbib (Ari)
Number of employees88000
Security typeOrdinary Share
Fiscal year-endMay 09
Address2400 Ellis Road
CityDURHAM
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code27703
Phone19199982000
Websitehttps://ir.iqvia.com/
Ticker SymbolIQV
IPO dateMay 09, 2013
CEOBousbib (Ari)
Company Executives of IQVIA Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.41M
+2.04%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
65.53K
+14.55%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
30.89K
+15.83%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.32K
+5.25%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
16.95K
+9.27%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
14.45K
+10.87%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
5.96K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
3.03K
+71.48%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
1.06K
--
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.41M
+2.04%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
65.53K
+14.55%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
30.89K
+15.83%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.32K
+5.25%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
16.95K
+9.27%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
14.45K
+10.87%
FAQs
Who are the top five shareholders of IQVIA Holdings Inc?
The top five shareholders of IQVIA Holdings Inc are: Mr. Ari Bousbib
How many institutions hold shares of IQVIA Holdings Inc (IQV)?
As of 2026Q1, 2209 institutions hold shares of IQVIA Holdings Inc, with a combined market value of approximately 173.06M, accounting for 103.69% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -9598327.00.
